白花蛇草舌草
猫爪草
冬稜草
山慈菇
石見穿
The five herbs you listed are commonly discussed in Traditional Chinese Medicine (TCM) in relation to tumors/cancer, particularly as “清热解毒、散结、消肿” herbs. However, they should not be considered proven cancer cures. Modern evidence for these individual herbs is mostly laboratory/animal research, with much less high-quality human evidence. Reviews of Chinese herbal medicine similarly conclude that evidence quality is often insufficient for firm cancer-treatment recommendations.
Your 5 herbs
| Chinese herb | Pinyin | Common English name | Traditional TCM role |
|---|
| 白花蛇舌草 | Bái Huā Shé Shé Cǎo | Hedyotis/Oldenlandia diffusa | 清热解毒、消痈、利湿 |
| 猫爪草 | Māo Zhǎo Cǎo | Ranunculus ternatus | 化痰散结、消肿 |
| 冬凌草 | Dōng Líng Cǎo | Rabdosia rubescens | 清热解毒、消肿散结 |
| 山慈菇 | Shān Cí Gū | Cremastra/Pleione pseudobulb | 清热解毒、消肿散结 |
| 石见穿 | Shí Jiàn Chuān | Salvia chinensis | 活血化瘀、清热解毒、散结 |
Why these five are often put together
From a traditional TCM perspective, the combination is aimed at several overlapping concepts:
热毒 → 清热解毒
白花蛇舌草、冬凌草、山慈菇
痰结/肿块 → 化痰散结、消肿
猫爪草、山慈菇、冬凌草
瘀血/固定肿块 → 活血化瘀
石见穿
So a TCM practitioner might regard this as a “清热解毒 + 散结消肿 + 活血” group rather than simply five “anti-cancer herbs.”
Important distinction
Some laboratory studies of heat-clearing/detoxifying TCM herbs have reported mechanisms such as apoptosis, inhibition of proliferation, angiogenesis and metastasis. But activity against cancer cells in a laboratory is not equivalent to demonstrating that an herb treats cancer in humans.
For example, the U.S. National Cancer Institute recognizes that some Chinese herbal formulations are being investigated as adjuncts to conventional cancer treatment, but that does not establish that individual herbs can replace surgery, chemotherapy, radiation, targeted therapy or immunotherapy.
⚠️ One particularly important point
If someone has cancer and is receiving chemotherapy, radiotherapy, immunotherapy or targeted therapy, don't automatically combine these five herbs without the oncologist and a qualified TCM physician checking the exact regimen. Herbal products can have drug interactions, affect liver/kidney function, or alter drug metabolism. NCI specifically warns that “natural” does not necessarily mean safe and that herbal products can interact negatively with medicines.
I checked the available research literature for all five. The important point is that the strongest evidence is still preclinical, although some of these herbs have a long history of TCM use and some have been studied as adjuncts in cancer care.
1. 白花蛇舌草 — Hedyotis diffusa
TCM: 清热解毒、消痈、利湿、散结
Common research name: Hedyotis diffusa Willd.
What research shows
This is probably one of the most extensively researched herbs on your list.
Research has identified numerous constituents, including iridoids, flavonoids, anthraquinones, phenolic compounds and polysaccharides. Laboratory/animal research has reported:
-
inhibition of cancer-cell proliferation
-
induction of apoptosis
-
effects on angiogenesis
-
immune modulation
-
anti-inflammatory effects
-
possible effects on autophagy
A systematic review identified 58 potentially active antitumor constituents and multiple proposed mechanisms.
Cancers investigated
Research has included models involving:
-
liver cancer
-
colorectal cancer
-
gastric cancer
-
lung cancer
-
breast cancer
-
nasopharyngeal cancer
-
leukemia and others
But this does not mean it has been clinically proven to treat all these cancers.
Typical TCM dosage
A commonly cited decoction range is approximately 15–30 g/day, although clinical prescriptions may differ considerably according to the individual pattern.
2. 猫爪草 — Ranunculus ternatus
TCM: 化痰散结、消肿
Botanical: Ranunculus ternatus Thunb.
This herb is particularly interesting when the TCM objective is “痰结、瘰疬、结块”.
Modern research
Recent research has investigated it against:
-
esophageal squamous-cell carcinoma
-
colorectal cancer
-
breast cancer
-
lymphoma/cancer-cell models
A 2025 study found that extracts affected MAPK/ERK and PI3K/Akt signaling in esophageal cancer cell models.
Another 2025 study investigated its alkaloid fraction in colorectal-cancer models and reported inhibition of epithelial-mesenchymal transition and metastasis-related processes.
A separate 2025 study investigated its saponins in breast-cancer models and reported effects involving JAK2/STAT3 signaling, tumor growth and apoptosis.
Important limitation
These are primarily cell and animal experiments, not evidence that taking 猫爪草 will stop cancer in humans.
Traditional dosage
TCM clinical prescriptions commonly use approximately 15–30 g, but dosage should be individualized.
3. 冬凌草 — Rabdosia rubescens
TCM: 清热解毒、消肿散结
Major compound: Oridonin(冬凌草甲素)
Of your five herbs, this one has particularly interesting molecular cancer research.
Oridonin
Oridonin is a diterpenoid isolated from Rabdosia rubescens.
Research has reported:
-
apoptosis
-
cell-cycle arrest
-
inhibition of angiogenesis
-
inhibition of migration/invasion
-
possible ferroptosis
-
effects on NF-κB
-
PI3K/Akt pathway effects
-
possible reversal of drug resistance
A 2024 comprehensive review summarized research involving oridonin and multiple cancer models.
For example, laboratory and animal experiments have found inhibition of oral squamous-cell carcinoma through effects on PI3K/Akt signaling and apoptosis.
Clinical evidence
There is more clinical experience with Rabdosia rubescens preparations than with some of the other herbs on your list. A recent review reports that preparations such as tablets, syrups and other formulations have been investigated as adjunctive cancer therapies.
However, that still doesn't establish 冬凌草 alone as a replacement for standard cancer treatment.
Typical TCM dosage
Some Chinese clinical literature uses approximately 15–30 g, with higher doses sometimes appearing in specialist prescriptions. One clinical discussion reported 30–60 g in particular pulmonary-nodule prescriptions, illustrating why dosage should not simply be copied from another formula.
4. 山慈菇 — Cremastra appendiculata / related medicinal species
TCM: 清热解毒、消肿散结
Important: “山慈菇” is a name that can refer to different botanical sources in Chinese medicine, so the actual species/product should be confirmed before buying or prescribing it.
Cancer research
Research has investigated Cremastra appendiculata preparations/compounds in:
-
breast cancer
-
other tumor models
-
inflammatory and proliferative pathways
For example, network-pharmacology research has investigated Cremastra appendiculata against breast cancer and proposed multiple molecular targets and pathways.
But this area has substantially less convincing human clinical evidence than conventional cancer therapies.
Traditional role
From a TCM perspective, 山慈菇 is particularly associated with:
散结 + 消肿 + 解毒
Therefore it is traditionally considered when there is a mass, nodule, swelling or “结”.
5. 石见穿 — Salvia chinensis
TCM: 清热解毒、活血化瘀、散结
Botanical: Salvia chinensis Benth.
This herb is particularly interesting because it combines two traditional concepts:
清热解毒 + 活血散结
Cancer research
Research has examined:
-
hepatocellular carcinoma
-
breast cancer
-
pancreatic cancer
-
lung cancer
-
colorectal cancer
Studies have investigated its polysaccharides, polyphenols and other constituents.
For example, animal research found that polysaccharides from Salvia chinensis affected immune responses in a transplanted hepatocellular-carcinoma model.
Another study investigated its effects in triple-negative breast-cancer models and identified compounds including quercetin and β-sitosterol.
Caution: one older pancreatic-cancer paper involving Salvia chinensis extract was subsequently retracted, so that particular result should not be used as evidence.
Side-by-side comparison
| Herb | Main TCM concept | Interesting research area | Evidence level |
|---|
| 白花蛇舌草 | 清热解毒、利湿散结 | Apoptosis, immune modulation, angiogenesis | 🟡 Mostly preclinical |
| 猫爪草 | 化痰散结 | Esophageal, colorectal, breast models | 🟡 Mostly preclinical |
| 冬凌草 | 清热解毒、散结 | Oridonin, apoptosis, cell cycle | 🟡 Preclinical + some clinical adjunct experience |
| 山慈菇 | 解毒、消肿散结 | Breast cancer/molecular studies | 🟠 Limited human evidence |
| 石见穿 | 清热解毒、活血散结 | Liver, breast and other cancer models | 🟡 Mostly preclinical |
A useful way to understand the five
From a TCM formulation perspective, they are not five identical “anti-cancer herbs”:
白花蛇舌草
→ 清热解毒
冬凌草
→ 清热解毒 + 散结
猫爪草
→ 化痰 + 散结
山慈菇
→ 解毒 + 消肿 + 散结
石见穿
→ 清热解毒 + 活血 + 散结
So the conceptual combination is:
清热解毒 + 化痰散结 + 消肿 + 活血化瘀
That explains why combinations containing several of these herbs appear in some TCM oncology prescriptions. For example, Chinese clinical literature describes prescriptions combining 白花蛇舌草、猫爪草、冬凌草 and 石见穿 according to the patient's presentation.
⚠️ Don't simply combine all five yourself
I would not recommend making a five-herb cancer formula from these numbers alone. Cancer treatment requires knowing the cancer type, stage, pathology, current drugs and liver/kidney function.
Also, the research doses used in cell experiments or animal studies cannot be converted directly into a safe human dose.
If someone is undergoing chemotherapy, immunotherapy, targeted therapy or radiotherapy, the herbal combination should be checked for interactions before use.
If your goal is specifically “which of these five has the strongest cancer research?”
Based on the literature I found, I would roughly divide them:
Research interest:
🥇 冬凌草 / Oridonin
🥈 白花蛇舌草
🥉 猫爪草
4️⃣ 石见穿
5️⃣ 山慈菇
For a single cancer patient, I would not give a fixed five-herb dosage based only on the cancer diagnosis. The appropriate dose depends on the cancer type/stage, treatment, liver/kidney function, other medicines, and the exact botanical product.
The key reason is that there is no well-established, evidence-based anticancer dosage for this five-herb combination in humans. NCI specifically warns that herbs can alter cancer-drug absorption/metabolism and potentially cause adverse outcomes.
If you mean traditional TCM raw-herb dosage
These are general traditional prescription ranges, not a recommendation for a particular patient:
| Herb | Common traditional decoction range |
|---|
| 白花蛇舌草 | 15–30 g/day |
| 猫爪草 | 10–30 g/day |
| 冬凌草 | 10–30 g/day |
| 山慈菇 | 3–9 g/day |
| 石见穿 | 15–30 g/day |
Do not simply add the maximum of every range together. That could produce a substantially different formula from what a TCM physician would prescribe.
Also, 山慈菇 needs particular attention to botanical identification, because products sold under this Chinese name can represent different medicinal species.
If the patient is currently receiving cancer treatment
I would not start all five herbs simultaneously without the oncologist/qualified TCM practitioner reviewing the cancer medicines. Even herbal formulations that are being investigated as adjuncts to cancer therapy are studied at specific formulations and doses—not simply as arbitrary combinations.
If you give me these 5 details, I can make the dosage discussion much more specific and safer:
-
Cancer type — e.g. lung, liver, colon, prostate, breast
-
Stage
-
Age and sex
-
Current cancer treatment/medications — chemotherapy, immunotherapy, targeted therapy, etc.
-
Liver/kidney problems or normal?